CHICAGO, July 4, 2022
/PRNewswire/ -- According to the new market research report
"Research Antibodies and Reagents Market by Product
(Antibodies (Type, Form, Source, Research Area), Reagents),
Technology (Western blot, Flow Cytometry, ELISA), Application
(Proteomics, Genomics), End User (Pharma, Biotech, CROs) - Global
forecast to 2027", published by MarketsandMarkets™,
the global Research Antibodies and Reagents Market are
projected to reach USD 16.1 billion
by 2027 from USD 11.6 billion in
2022, at a CAGR of 6.7% during the forecast period.
Browse in-depth TOC on "Research Antibodies Market and
Research Reagents Market"
244 – Tables
46 – Figures
285 – Pages
Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94212793
The Factors responsible for driving the market are, increasing
growth in proteomics and genomics research, growing demand for
high-quality antibodies for research reproducibility, and
increasing R&D investments in the life sciences industry.
The antibodies segment is expected to grow at the highest
CAGR during the forecast period
On the basis of product, the research antibodies and reagents
market are segmented into reagents and antibodies. The antibodies
segment is expected to grow at highest CAGR in forecast periods
(2022-2027). Factors such as antibodies use for research offer high
specificity and selectivity and are used ubiquitously in
biochemical and medical research for protein-target identification,
regulatory characterization, and discovery, are driving the
market.
The primary antibodies segment is accounts for the largest
share of the research antibodies and reagents market
On the basis of type, the research reagents market are segmented
into primary antibodies and secondary antibodies. In 2021, the
primary antibodies segment held the largest share of the global
research antibodies market. This segment is witnessing a strong
growth due to the use of these antibodies in numerous types of
assay formats. Their accuracy in biomarker detection and high
specificity and sensitivity are also driving the market.
The media & sera reagent is expected to account for the
largest share of the market, by type, in 2021
On the Basis of type, the research antibodies and reagents
market are segmented into media &sera, stains & dyes,
fixatives, buffers, solvents, enzymes, probes, and other reagents.
In 2021, the media & sera reagent segment held the largest
share of the global research antibodies market. Factors such as use
of these components in all types of assays, cell cultures, and
techniques is driving the market.
Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=94212793
The western blotting segment is expected to account for the
largest share of the market, by technology, in 2021
On the basis of technology, the research antibodies and reagents
market are segmented into western blotting, flow cytometry, ELISA,
Immunohistochemistry, Immunofluorescence, Immunoprecipitation, and
other technologies. The Western blotting segment is expected to
grow at highest CAGR in forecast periods (2022-2027). Factors such
as the high adoption of technique in proteomic and genomic
research. The results achieved are unique, easy to interpret, and
unambiguous, making it suited for evaluating levels of protein
expression in cells, protein purification, and comparing the
expression of a target protein from various tissues.
The drug development applications segment is expected to grow
at the highest CAGR during the forecast period
On the basis of application, the research antibodies and
reagents market are segmented into proteomics, drug development and
Genomics. The drug development segment is expected to grow at
highest CAGR in forecast periods (2022-2027). Factors such
increasing demand for personalized medicine and government funding
& initiatives in the sector are the key market drivers for this
segment.
The pharmaceutical & biotechnology segment is expected to
grow at the highest CAGR during the forecast period
On the basis of end user, the research antibodies and reagents
market are segmented into the pharmaceutical & biotechnology
companies, academic & research institutions, and ontract
Research Organizations. Factors such as the growth of this segment
is due to antibodies provide a gold standard for the detection of a
biomolecule or a pathway and are even capable of detecting specific
changes in potential drug targets. Moreover, highly specific
reagents are used to measure pharmacokinetic parameters in the
preclinical and clinical development of biological drugs are the
key market drivers for this segment.
Speak to Analyst:
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=94212793
The APAC market is expected to grow at the highest CAGR
during the forecast period
The Asia Pacific research
reagents market is expected to grow at the highest CAGR from 2022
to 2027. Factors such as increasing proteomics and genomics
research and growing research funding, increasing investments by
pharmaceutical and biotechnology companies are driving the
market.
The prominent market players are Thermo Fisher Scientific, Inc.
(US), Merck KGaA (Germany), Abcam
plc (UK), Becton, Dickinson, and Company (US), Bio-Rad Laboratories
(US), Cell Signaling Technology (US), F. Hoffmann-La Roche
(Switzerland), Danaher Corporation
(US), Agilent Technologies (US), PerkinElmer (US), Lonza
(Switzerland), GenScript
(China), and BioLegend (US).
Browse Adjacent Markets: Biotechnology Market
Research Reports & Consulting
Browse Related Reports:
Flow Cytometry Market by Technology (Cell-based,
Bead-based), Product (Analyzer, Sorter, Reagents, Consumables,
Software), End user (Academia, Research Labs, Hospitals, Clinical
Laboratories, Pharma-Biotech Cos), Application - Global Forecasts
to 2025
https://www.marketsandmarkets.com/Market-Reports/flow-cytometry-market-65374584.html
Custom Antibody Market by Service (Antibody Production,
Characterization, Immunization, Fragmentation), Type (Monoclonal,
Polyclonal, Recombinant), Source (Mouse, Rabbit), Research Area
(Oncology, Immunology), and End Users - Global Forecast to 2023
https://www.marketsandmarkets.com/Market-Reports/custom-antibody-market-164328301.html
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000
high growth niche opportunities/threats which will impact 70% to
80% of worldwide companies' revenues. Currently servicing 7500
customers worldwide including 80% of global Fortune 1000 companies
as clients. Almost 75,000 top officers across eight industries
worldwide approach MarketsandMarkets™ for their painpoints around
revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are
tracking global high growth markets following the "Growth
Engagement Model – GEM". The GEM aims at proactive collaboration
with the clients to identify new opportunities, identify most
important customers, write "Attack, avoid and defend" strategies,
identify sources of incremental revenues for both the company and
its competitors. MarketsandMarkets™ now coming up with 1,500
MicroQuadrants (Positioning top players across leaders, emerging
companies, innovators, strategic players) annually in high growth
emerging segments. MarketsandMarkets™ is determined to benefit more
than 10,000 companies this year for their revenue planning and help
them take their innovations/disruptions early to the market by
providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market
research platform, "Knowledge Store" connects over 200,000 markets
and entire value chains for deeper understanding of the unmet
insights along with market sizing and forecasts of niche
markets.
Contact:
Mr. Aashish
Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Research Insight:
https://www.marketsandmarkets.com/ResearchInsight/research-antibodies-reagents-market.asp
Visit Our Web Site: https://www.marketsandmarkets.com
Content Source:
https://www.marketsandmarkets.com/PressReleases/research-antibodies-reagents.asp
Logo:
https://mma.prnewswire.com/media/660509/MarketsandMarkets_Logo.jpg
View original
content:https://www.prnewswire.com/news-releases/research-antibodies-and-reagents-market-worth-16-1-billion-by-2027--exclusive-report-by-marketsandmarkets-301580150.html
SOURCE MarketsandMarkets